After a year of customer pullbacks, biologics CDMO Avid Bioservices will be taken private by GHO Capital Partners and Ampersand Capital Partners in a deal worth $1.1 billion. “In evaluating ...
Anna Brown is a Biopharma Breaking News Reporter, covering the latest developments and breakthroughs in the biopharmaceutical industry. With a focus on providing accurate and timely information, Anna's work has been featured in publications such as Endpoints News, Laconia Daily Sun, Wiley, and Star Observer. She is dedicated to delivering insightful and comprehensive coverage of the biopharma sector to keep readers informed and engaged.